Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BERKELEY, CA--(Marketwire - Oct 6, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the results of a prospective analysis of the diabetic subset population from its Phase 3...
-
BERKELEY, CA--(Marketwire - Oct 5, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) and AstraZeneca have amended their existing Collaboration Agreement to accelerate the initiation of...
-
BERKELEY, CA--(Marketwire - Oct 3, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) presented yesterday at the 5th Global Vaccine Congress in Seattle, WA an analysis of the modified intent...
-
BERKELEY, CA--(Marketwire - Sep 18, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) today at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago, IL...
-
BERKELEY, CA--(Marketwire - Sep 16, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that on Sunday, September 18, at 11:30 am CDT at the 51st Interscience Conference on...
-
BERKELEY, CA--(Marketwire - Sep 16, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the UBS Global Life Sciences Conference in New York on...
-
BERKELEY, CA--(Marketwire - Sep 7, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the receipt of a two-year Small Business Innovation Research grant (SBIR) for $600,000....
-
BERKELEY, CA--(Marketwire - Sep 1, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at William Blair & Company's 2011 Life Sciences Conference in...
-
BERKELEY, CA--(Marketwire - Aug 11, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the Wedbush 2011 Life Sciences Conference in New York on...
-
BERKELEY, CA--(Marketwire - Jul 28, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug...